BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 13, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Other news to note for June 30, 2021

June 30, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abcuro, Aditum, Ancora, Alligator, Alpine, Athersys, Bioaegis, Biogen, Cenexi, Clover, Cytovation, Dynavax, Elevation, Enochian, Genomic Testing Cooperative, Glaxosmithkline, ICER, Imaginab, Merck & Co., Nimble, Olimmune, Ose, Rayzebio, Scandion, Scopus, Siga, Taisho, Vir.
Read More

In the clinic for June 30, 2021

June 30, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Addex, Astrazeneca, Brim, Celularity, Cerevel, Ciclomed, Compass Pathways, Elicio, F-star, Harmony, Horizon, Iovance, Moderna, Orchard, Pfizer, Propella, Synthetic Biologics, Trillium, VBI.
Read More
European Union map and coronavirus

EMA looking for legal boost to better deal with future pandemics

June 29, 2021
By Nuala Moran
LONDON – Moves to expand the legal remit of the European Medicines Agency (EMA) and give it more powers to deal with the COVID-19 pandemic and future health emergencies are moving to fruition, after the European Parliament and national health ministers in the European Council separately voted through the proposal.
Read More

Other news to note for June 29, 2021

June 29, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advanced Accelerator Applications, Avacta, Avicenna.AI, B. Braun, Bioivt, Cancer Targeted Technology, Cognetivity Neurosciences, Ethicon, Medline Industries, Merck, Neuroloop, Novacyt, Nuance, Orthofix Medical, Qiagen, Teleflex, Valley Biomedical Products & Services, Verogen.
Read More

Regulatory actions for June 29, 2021

June 29, 2021
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abiomed, Attana, Front Line Medical, Galderma, Neuros Medical.
Read More
Europe under magnifier/petri dish with coronavirus

COVID-19 therapies advance in EU, not so much a U.S. priority

June 29, 2021
By Mari Serebrov
As a first step in developing a portfolio of COVID-19 therapies, the European Commission identified five promising candidates June 29, including four monoclonal antibodies under rolling review at the EMA and an immunosuppressant that could have its marketing authorization extended to include the treatment of COVID-19 infections.
Read More

Regulatory actions for June 29, 2021

June 29, 2021
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Agios, Asklepios, Astrazeneca, Atsena, Biomarin, Biontech, Braeburn, Camurus, Catalyst, Cend, Chugai, Genentech, Immunicum, Innocare, Innovent, Junshi, Kymera, Moderna, Oric, Pfizer, Regeneron, Roche, Rockwell, Saniona, Sanofi, Syndax, Zentalis.
Read More

Other news to note for June 29, 2021

June 29, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acrivon, Amgen, Antios, Applied Biomath, APR, Arbutus, Astrazeneca, Baymedica, Brigham and Women's Hospital, Cannex, Carmot, Cell and Gene Therapy Catapult, Compugen, Curie Institute, Defence, Diurnal, Elevatebio, E r-Kim, Etherna, Ichnos, Inmed, Innovent, Ixaka, KBI, Lilly, Mosaic Biosciences, Mosaic Immunoengineering, Ocular, Paratek, PYC, Q-State, Quantoom, Relief, Selexis, Simcere, Somalogic, Synaffix, Vivoryon.
Read More

In the clinic for June 29, 2021

June 29, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Achieve, Clovis, Dare, Hoth, Ideaya, Intellia, Kymera, Maat, Neurophth, Onconova, Pinteon, Precision Biosciences, Regenerative Patch, Regeneron, RDIF, Rigel, Sab, Sanofi, Springworks, Zentalis.
Read More

Other news to note for June 28, 2021

June 28, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Asensus Surgical US, DNA Diagnostics Center, Eurofins Scientific, Meridian Bioscience, Newpace, Powermat Technologies, Red One Medical, Rockwell Medical.
Read More
Previous 1 2 … 216 217 218 219 220 221 222 223 224 … 552 553 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 13, 2026.
  • Brain maze

    Alzheimer’s, beyond the brain

    BioWorld
    Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 12, 2026
  • Hantavirus zoonotic spillover illustration

    First cruise ship hantavirus genome points to zoonotic spillover

    BioWorld
    The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
  • Test tubes, dropper and capsules

    Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal

    BioWorld
    In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing